ArticleAnnals of Ibadan postgraduate medicine2023
CLINICO-DEMOGRAPHIC PROFILE AND TREATMENT OF PATIENTS WITH PROSTATE CANCER IN A NORTH- CENTRAL NIGERIAN TEACHING HOSPITAL.
Article in Annals of Ibadan postgraduate medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
- Prostate Cancer Management in Nigeria: A mini-review of up-to-date treatment options.Nigerian medical journal : journal of the Nigeria Medical AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prostate cancer is one of the most common malignancies afflicting men worldwide. In the male population, it is estimated that one in seven will be diagnosed and one in 38 will die from prostate cancer. Majority of patients in Sub Saharan Africa present with advanced disease. Objective: To identify among prostate cancer patients, the age, clinical manifestation and stage at presentation as well as treatment received. Materials and Method: The study reviewed patients with prostate cancer at the Jos University Teaching Hospital between January 2014 and December 2017. The demographic and clinical characteristics as well as treatment given were analysed. Results: A total of 82 patients were studied. Age range was 41-100 years with a median of 67.9 years. The peak age group was 71-80 years, accounting for 41.4% of patients. Lower urinary tract symptom was present in all patients at the time of presentation. 59.8% of these patients presented with metastatic symptoms. Persistent low back pain was seen in 61.2 % of patients with metastatic symptoms, and digital rectal examination was suggestive of malignancy in 62.2% of patients. PSA was >20ng/ml in 73.3% of patients. Histology for all patients was adenocarcinoma, with a predominant Gleason score of 8 (29.3%). Bilateral total orchidectomy was offered in 59.8% of patients. Conclusion: Majority of patients with carcinoma of the prostate in Jos have features of metastasis at the time of diagnosis. Orchidectomy is the most common treatment offered in our environment.
Indexed as
Identifiers
38298345PMC10811711W4394761472What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.